Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 21351093)

Published in Int J Cancer on April 20, 2011

Authors

Miluse Hubackova1, Radka Vaclavikova, Marie Ehrlichova, Marcela Mrhalova, Roman Kodet, Katerina Kubackova, David Vrána, Ivan Gut, Pavel Soucek

Author Affiliations

1: Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.

Associated clinical trials:

IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer (Neonab) | NCT01830244

Articles citing this

Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis. Cancer Med (2016) 0.86

Correlation between superoxide dismutase 1 and 2 polymorphisms and susceptibility to oral squamous cell carcinoma. Exp Ther Med (2013) 0.81

Manganese superoxide dismutase and breast cancer recurrence: a Danish clinical registry-based case-control study, and a meta-analysis. PLoS One (2014) 0.80

Oxidative stress in susceptibility to breast cancer: study in Spanish population. BMC Cancer (2014) 0.79

Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study. BMC Cancer (2012) 0.79

The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties. FEBS Lett (2014) 0.78

The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients. Medicine (Baltimore) (2014) 0.77

Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes. PLoS One (2015) 0.75

Inbreeding and homozygosity in breast cancer survival. Sci Rep (2015) 0.75

Azoreductases in drug metabolism. Br J Pharmacol (2016) 0.75

Identification of candidate polymorphisms on stress oxidative and DNA damage repair genes related with clinical outcome in breast cancer patients. Int J Mol Sci (2012) 0.75

Analyses of antioxidant status and nucleotide alterations in genes encoding antioxidant enzymes in patients with benign and malignant thyroid disorders. PeerJ (2017) 0.75

Articles by these authors

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA (2006) 5.51

Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis (2004) 1.28

Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch (2001) 1.23

Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 1.17

Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis (2006) 1.11

Demographic and risk factors in patients with head and neck tumors. J Med Virol (2009) 1.10

Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network. J Hematop (2009) 1.07

Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis (2010) 1.07

Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs. Drug Metab Dispos (2004) 1.05

Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Mod Pathol (2003) 1.03

The expression profile of ATP-binding cassette transporter genes in breast carcinoma. Pharmacogenomics (2013) 1.01

Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population. Oncol Rep (2010) 1.01

Somatic TP53 mutation mosaicism in a patient with Li-Fraumeni syndrome. Am J Med Genet A (2009) 0.97

Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas. Clin Cancer Res (2012) 0.97

A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIalpha, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma. Virchows Arch (2010) 0.96

Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95

Markers of individual susceptibility and DNA repair rate in workers exposed to xenobiotics in a tire plant. Environ Mol Mutagen (2004) 0.95

Angiosarcoma of the thyroid. Eur Arch Otorhinolaryngol (2008) 0.94

The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population. Eur J Cancer (2008) 0.93

Identification of potential human oncogenes by mapping the common viral integration sites in avian nephroblastoma. Cancer Res (2006) 0.92

Different antioxidant effects of polyphenols on lipid peroxidation and hydroxyl radicals in the NADPH-, Fe-ascorbate- and Fe-microsomal systems. Biochem Pharmacol (2003) 0.91

Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel. Am J Surg Pathol (2011) 0.91

Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and nonneoplastic tissues. Pancreas (2013) 0.91

Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma. Eur J Cancer (2004) 0.90

Coincidence of thyroid tumor and thyroglossal duct remnants. Review of the literature and presentation of three cases. Tumori (2003) 0.88

Breast cancer: role of polymorphisms in biotransformation enzymes. Eur J Hum Genet (2004) 0.88

Chromosomal aberrations in tire plant workers and interaction with polymorphisms of biotransformation and DNA repair genes. Mutat Res (2008) 0.87

Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer (2005) 0.87

New model system for testing effects of flavonoids on doxorubicin-related formation of hydroxyl radicals. Anticancer Drugs (2011) 0.87

Superoxide dismutase and nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase polymorphisms and pancreatic cancer risk. Pancreas (2011) 0.87

Localization of genetic elements of intact and derivative chromosome 11 and 22 territories in nuclei of Ewing sarcoma cells. J Struct Biol (2006) 0.87

Defining the glycophenotype of squamous epithelia using plant and mammalian lectins. Differentiation-dependent expression of alpha2,6- and alpha2,3-linked N-acetylneuraminic acid in squamous epithelia and carcinomas, and its differential effect on binding of the endogenous lectins galectins-1 and -3. APMIS (2002) 0.87

ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep (2013) 0.86

Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors. Int J Cancer (2012) 0.86

Variation in the vitamin D receptor gene is not associated with risk of colorectal cancer in the Czech Republic. J Gastrointest Cancer (2011) 0.86

A Li-Fraumeni syndrome family with retained heterozygosity for a germline TP53 mutation in two tumors. Cancer Genet Cytogenet (2003) 0.85

Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.85

Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells. Anticancer Res (2009) 0.85

Evaluation of reference genes and normalization strategy for quantitative real-time PCR in human pancreatic carcinoma. Dis Markers (2012) 0.85

Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells. Invest New Drugs (2009) 0.84

Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations. Breast Cancer Res Treat (2007) 0.84

Differential expression and prognostic role of selected genes in colorectal cancer patients. Anticancer Res (2013) 0.84

Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database. Leuk Lymphoma (2013) 0.84

RNA expression of cytochrome P450 in breast cancer patients. Anticancer Res (2008) 0.84

Genetic polymorphisms and possible gene-gene interactions in metabolic and DNA repair genes: effects on DNA damage. Mutat Res (2005) 0.84

The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer. Cancer Chemother Pharmacol (2013) 0.83

Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma. Virchows Arch (2010) 0.83

The environmental pollutant and carcinogen 3-nitrobenzanthrone and its human metabolite 3-aminobenzanthrone are potent inducers of rat hepatic cytochromes P450 1A1 and -1A2 and NAD(P)H:quinone oxidoreductase. Drug Metab Dispos (2006) 0.83

The oxidative metabolism of dimemorfan by human cytochrome P450 enzymes. J Pharm Sci (2010) 0.83

CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk. Pancreas (2010) 0.82

Tumor-infiltrating lymphocytes and dendritic cells in human colorectal cancer: their relationship to KRAS mutational status and disease recurrence. Hum Immunol (2011) 0.82

Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Cancer Epidemiol Biomarkers Prev (2012) 0.81

Molecular cytogenetic characterization in four pediatric pheochromocytomas and paragangliomas. Pathol Oncol Res (2011) 0.81

NBN 657del5 heterozygous mutations and colorectal cancer risk in the Czech Republic. Mutat Res (2009) 0.81

Minipig cytochrome P450 2E1: comparison with human enzyme. Drug Metab Dispos (2005) 0.81

Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients. Pharmacogenet Genomics (2008) 0.81

Malignant peripheral primitive neuroectodermal tumor of the kidney. Cancer Genet Cytogenet (2002) 0.80

Chromosomal damage and polymorphisms of DNA repair genes XRCC1 and XRCC3 in workers exposed to cytostatics. Neuro Endocrinol Lett (2006) 0.80

Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis. J Am Acad Dermatol (2012) 0.80

Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma. Cancer Genet Cytogenet (2009) 0.80

Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.80

New aspects in the biomonitoring of occupational exposure to styrene. Int Arch Occup Environ Health (2002) 0.79

Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders. Diagn Mol Pathol (2008) 0.79

Importance of transcript levels of caspase-2 isoforms S and L for breast carcinoma progression. Future Oncol (2013) 0.79

No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma. Leuk Res (2011) 0.79

Modulation of paclitaxel transport by flavonoid derivatives in human breast cancer cells. Is there a correlation between binding affinity to NBD of P-gp and modulation of transport? Bioorg Med Chem (2006) 0.79

Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: correlation with ERBB-2 protein expression and ERBB2 gene copy number. Pathol Res Pract (2003) 0.79

Differential inductive profiles of hepatic cytochrome P450s by the extracts of Sophora flavescens in male and female C57BL/6JNarl mice. J Ethnopharmacol (2009) 0.79

Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genes. Invest New Drugs (2011) 0.78

Multiplex single-tube screening for mutations in the Nijmegen Breakage Syndrome (NBS1) gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic origin. Eur J Hum Genet (2003) 0.78

Metabolic gene variants associated with chromosomal aberrations in healthy humans. Genes Chromosomes Cancer (2015) 0.78

Loss of adhesion/growth-regulatory galectin-9 from squamous cell epithelium in head and neck carcinomas. J Oral Pathol Med (2012) 0.78

Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis. Clin Chem Lab Med (2012) 0.78

Teratoma in an adolescent with malignant transformation into embryonal rhabdomyosarcoma: case report. J Pediatr Hematol Oncol (2006) 0.78

Quantitative PCR detection of NPM/ALK fusion gene and CD30 gene expression in patients with anaplastic large cell lymphoma--residual disease monitoring and a correlation with the disease status. Leuk Res (2007) 0.78

Cytochrome P450 destruction by benzene metabolites 1,4-benzoquinone and 1,4-hydroquinone and the formation of hydroxyl radicals in minipig liver microsomes. Toxicol In Vitro (2006) 0.78

Inter-species comparisons of hepatic cytochrome P450 enzyme levels in male ruminants. Arch Toxicol (2003) 0.78

Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague-Dawley/Cub rats. Eur J Pharm Sci (2006) 0.78

CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer. Cancer Epidemiol (2010) 0.77

Modulation of DNA repair capacity and mRNA expression levels of XRCC1, hOGG1 and XPC genes in styrene-exposed workers. Toxicol Appl Pharmacol (2010) 0.77

Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis. Anal Bioanal Chem (2014) 0.77

Scientists appeal to Quebec Premier Charest to stop exporting asbestos to the developing world. Int J Occup Environ Health (2010) 0.77

The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients. Medicine (Baltimore) (2014) 0.77